Salarius Pharmaceuticals Inc (SLRX) — Long-term Investment Intensity

Latest as of December 2015: 2.4%

Salarius Pharmaceuticals Inc (SLRX) has a Long-term Investment Intensity of 2.4% as of December 2015. Long-term investments of $2.31 Million represent 2.4% of total assets of $95.07 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check Salarius Pharmaceuticals Inc (SLRX) asset resilience to evaluate the company's liquid asset resilience ratio.

LT Investment Intensity

2.4%
LT Investments / Total Assets

Long-term Investments

$2.31 Million
USD

Total Assets

$95.07 Million
USD

Country

USA
NASDAQ

Salarius Pharmaceuticals Inc Long-term Investment Intensity (2015–2015)

This chart shows how Salarius Pharmaceuticals Inc's Long-term Investment Intensity has evolved across 1 annual periods from 2015 to 2015. As of December 2015, the intensity stands at 2.4%, reflecting long-term investments of $2.31 Million against total assets of $95.07 Million USD. For the complete balance sheet picture, see balance sheet size of Salarius Pharmaceuticals Inc.

Annual Long-term Investment Intensity for Salarius Pharmaceuticals Inc (2015–2015)

The table below presents the year-by-year Long-term Investment Intensity for Salarius Pharmaceuticals Inc from 2015 to 2015, covering 1 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. Read Salarius Pharmaceuticals Inc balance sheet liabilities for a breakdown of total debt and financial obligations.

Year LT Investment Intensity LT Investments (USD) Total Assets Change (pp)
2015 2.4% $2.31 Million $95.07 Million
pp = percentage points